Peptide | Moderate Risk

CJC-1295 (with DAC)

What to know about CJC-1295 (with DAC): uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

CJC-1295 (with DAC) is classified as Moderate risk (3 risk points) by AllMeds. Growth hormone releasing peptide. NOT TGA registered. Compounding only. Safety concerns.

Key Takeaways

  • Risk level: Moderate (3 points)

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) Unscheduled Not PBS listed

Risk Profile

Risk Level Moderate
Risk Points 3
CNS Depressant No
Respiratory Risk No

Growth hormone releasing peptide. NOT TGA registered. Compounding only. Safety concerns.

How CJC-1295 (with DAC) is regulated

CJC-1295 (with DAC) is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Australia TGA / PBS / State Schemes

Classified as Unscheduled under the Therapeutic Goods Administration (TGA).

Clinical Evidence

  • Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295 - Teichman SL, et al. (2006)

    Phase I/II clinical trial showing CJC-1295 increases GH and IGF-1 levels. Study by ConjuChem (manufacturer). Development discontinued.

    Published human trial but drug development was abandoned — manufacturer-funded

  • Deaths linked to peptide use in bodybuilding community - ABC News Australia (2023)

    Multiple Australian media reports of adverse events associated with GH-releasing peptides obtained from unregulated sources.

    Major national broadcaster — credible journalism

  • TGA: Growth hormone secretagogue peptides — safety concerns - TGA (2023)

    TGA warns that GH-releasing peptides from compounding pharmacies are not registered medicines. Quality, safety, and efficacy not established.

    Australian regulatory authority

Check this medication against your full medication list

Run a full risk assessment including CJC-1295 (with DAC) interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Try it free → Talk to Sales →

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.